Pushkar D Yu, Bernikov A N, Khodyreva L A, Dudareva A A, Al'-Shukri S Kh, Amdii R E, Aboyan I A, Shiranov K A, Medvedev V L, Efremov M E
A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia.
First Pavlov State Medical University of St. Petersburg of Minzdrav of Russia, St. Petersburg, Russia.
Urologiia. 2018 Mar(1):53-61.
To date, the gold standard for the surgical management of BPH is transurethral resection of the prostate (TURP). Most patients who undergo TURP for BPH experience immediate effects and complete relief of lower urinary tract symptoms and do not need further urological care. However, some patients after this operation have some level of persistent residual lower urinary tract symptoms, which may require additional therapy.
To investigate voiding function and the need for medical therapy in patients who underwent TURP for LUTS due to BPH.
This study was performed as an anonymous survey among male patients presenting to a urology clinic. During the visit, the patients were offered to fill out I-PSS and SF-36 questionnaires. Also, they were asked about their socio-economic status, history of BPH, their perception of surgery and the postoperative period up to the day of the interview, presence or absence of symptoms of voiding dysfunction and any drug therapy at the time of the interview or after surgery. The patients also rated the severity of the symptoms using the IPSS questionnaire. The study comprised patients after 12 months to 3 years following successful TURP for LUTS due to BPH. A total of 1100 questionnaires were forwarded to researchers for interviewing patients who underwent TURP for prostatic hyperplasia.
After collecting and reviewing all the questionnaires, 921 questionnaires were found eligible. The findings of the survey showed that a significant proportion of patients who underwent TURP require a long-term postoperative medical therapy. At the same time, in the Russian Federation, there are no standard approaches to medical management of this category of patients.
迄今为止,良性前列腺增生(BPH)手术治疗的金标准是经尿道前列腺切除术(TURP)。大多数因BPH接受TURP的患者会立即感受到效果,下尿路症状完全缓解,无需进一步的泌尿外科护理。然而,一些接受该手术后的患者仍有一定程度的持续性残余下尿路症状,这可能需要额外的治疗。
调查因BPH导致下尿路症状(LUTS)而接受TURP的患者的排尿功能及药物治疗需求。
本研究以匿名调查的形式对一家泌尿外科诊所的男性患者进行。就诊期间,让患者填写国际前列腺症状评分(I-PSS)和简明健康状况调查量表(SF-36)问卷。此外,还询问了他们的社会经济状况、BPH病史、对手术的看法以及截至访谈当天的术后情况、是否存在排尿功能障碍症状以及访谈时或手术后的任何药物治疗情况。患者还使用I-PSS问卷对症状的严重程度进行评分。该研究纳入了因BPH导致LUTS而成功接受TURP术后12个月至3年的患者。总共向研究人员转发了1100份问卷,以便对因前列腺增生接受TURP的患者进行访谈。
在收集并审查所有问卷后,发现921份问卷符合要求。调查结果显示,相当一部分接受TURP的患者术后需要长期药物治疗。同时,在俄罗斯联邦,对于这类患者的药物管理没有标准方法。